Spravato and ketamine: what side effects to expect

What side effects to expect, when they happen, and how we monitor you.

Side effects and risks of Spravato and ketamine

Part 1 of 8

Most side effects happen on the day of treatment.

With Spravato (esketamine) and ketamine, the large majority of side effects happen on the treatment day itself.

They are concentrated in the first couple of hours after the dose, which is why you stay with us and are monitored for that time.

The evidence
FDA labeling / guidelines

The Spravato label describes dissociation as transient and occurring on the day of dosing, and nausea and vomiting as occurring mostly on the day of dosing and resolving the same day. Every session requires at least 2 hours of monitoring by a healthcare provider.

Ketamine given by infusion or injection for depression has been studied less systematically than Spravato. We monitor it the same way.

  1. Spravato (esketamine) prescribing information

Part 2 of 8

Dissociation: what it feels like.

Dissociation is the most common effect. More than half of people have some of it.

It varies a lot from person to person. People describe feeling detached from their body or their surroundings, a floating sensation, or a dream-like state.

Some people have intense emotional experiences, and some find them meaningful. Others notice very little, perhaps only that the walls look blurry.

Some people feel anxious during it. You are in a quiet room with staff close by, and we can give an anti-anxiety medicine when it is appropriate.

The evidence
FDA labeling / guidelines

In the Spravato trials, 61% to 75% of patients had dissociative or perceptual changes on a clinician-rated scale (CADSS), depending on dose and age. Dissociation was reported as a side effect by 41% of patients on Spravato and 9% on placebo, and anxiety by 13% and 6%.

Because of these effects, patients with psychosis are assessed carefully before treatment.

  1. Spravato (esketamine) prescribing information

Part 3 of 8

Sleepiness.

Ketamine was first used as an anesthetic, so it makes people sleepy even at the lower doses used in psychiatry. About half of people feel it.

It is strongest in the first hour after the dose and keeps wearing off through the second hour. We check on you throughout.

The evidence
FDA labeling / guidelines

In the Spravato trials, 48% to 61% of patients had sedation on an observer-rated scale (MOAA/S). Deep sedation and slowed breathing are rare, and they are the reason the label requires monitoring for at least 2 hours, including breathing and oxygen level.

  1. Spravato (esketamine) prescribing information

Part 4 of 8

Nausea.

About a quarter of people feel nauseated with Spravato, and about 1 in 10 vomit. It usually passes within an hour.

To lower the chance, do not eat for 2 hours before your dose and do not drink for 30 minutes before. We have anti-nausea medicine at the clinic.

The evidence
FDA labeling / guidelines

In the adult trials, nausea was reported by 28% of patients on Spravato and 9% on placebo, and vomiting by 9% and 2%. Most episodes occurred on the day of dosing, with a median duration of no more than 1 hour.

  1. Spravato (esketamine) prescribing information

Part 5 of 8

Blood pressure.

Ketamine and esketamine raise blood pressure for a while after each dose. The rise peaks about 40 minutes after the dose and settles over the next few hours.

We check your blood pressure before every treatment and again after the dose. If it is above our threshold when you arrive, we do not start treatment that day.

We have blood pressure medicine on hand if it is needed.

The evidence
FDA labeling / guidelines

Blood pressure increases peak at about 40 minutes and last about 4 hours. In the adult trials, 8% of patients on Spravato had a rise in systolic pressure of 40 mmHg or more and 11% had a rise in diastolic pressure of 25 mmHg or more, compared with 2% on placebo for each.

The label advises weighing risk and benefit when baseline pressure is above 140/90 mmHg. Spravato is not used in people with an aneurysm, an arteriovenous malformation, or a history of bleeding in the brain.

  1. Spravato (esketamine) prescribing information

Part 6 of 8

The rest of the day, and the next day.

For the rest of the day most people are slower and more tired than usual. You may not drive, and we discourage work or important decisions.

The next day, after a night of sleep, most people are back to themselves and can drive.

A small minority have a slight hangover feeling the next day. It wears off during that day.

The evidence
FDA labeling / guidelines

Patients should not drive or operate machinery until the next day after a restful sleep. In healthy volunteers, thinking speed dipped 40 minutes after a dose and was comparable to placebo by 2 hours.

  1. Spravato (esketamine) prescribing information

Part 7 of 8

The bladder question.

When ketamine is misused at very high doses, every day, for long periods, it can damage the bladder. This is a painful condition called interstitial cystitis.

It is not commonly seen in people receiving ketamine or esketamine at treatment doses and treatment frequencies.

Tell us if you notice pain when you urinate, or a need to go much more often. We ask about it during treatment.

The evidence
FDA labeling / guidelines

Ulcerative or interstitial cystitis has been reported with long-term off-label use or misuse of ketamine. In Spravato studies lasting up to a year, no cases of esketamine-related interstitial cystitis were observed. Milder urinary symptoms were more frequent than with placebo; urinary frequency was reported by 3% and 0.5%. The label recommends monitoring for urinary symptoms.

  1. Spravato (esketamine) prescribing information

Part 8 of 8

Over the longer term.

In studies that followed patients on Spravato for one to three years, memory and thinking stayed stable.

Weight gain and sexual side effects, two common reasons people stop daily antidepressant pills, are not among the common side effects of Spravato.

Ketamine and esketamine can be misused, which is one reason every dose is given here. We also check on your mood and safety at each visit.

These medicines are not recommended during pregnancy or breastfeeding. Tell us if you are pregnant or planning to be.

The evidence
FDA labeling / guidelines

In 1-year and 3-year open-label studies, cognitive performance remained stable with Spravato. Long-term cognitive impairment has been reported with repeated ketamine misuse. Weight gain and sexual dysfunction do not appear among the common adverse reactions in the label.

The label carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors, and Spravato is dispensed only through a restricted program (REMS). Long-term data for ketamine by infusion or injection are more limited.

  1. Spravato (esketamine) prescribing information
  2. Our guide: ketamine, esketamine and addiction
1 of 8

When side effects happen

Strongest in the first hour. Mostly gone by the time you leave.

Dose40 min1 hr2 hrBedtimeIn the clinic, monitoredAt home: tired, no driving

An illustration of the usual pattern, not measured data. The next morning, most people are back to themselves.

Out of 10 people

Some dissociationMore than half
SleepinessAbout half
NauseaAbout 1 in 4
VomitingAbout 1 in 10

Figures from the Spravato trials.

What we have on hand

  • Anti-nausea medicine
  • Blood pressure medicine
  • Anti-anxiety medicine, when appropriate

Staff are with you for the full monitoring period.

Tell us right away

  • Chest pain or trouble breathing
  • A severe headache or a change in vision
  • Pain when you urinate
  • Thoughts of harming yourself

After hours, call 911 or 988 in an emergency.

Before each treatment

  • Do not eat for 2 hours before your dose, and do not drink for 30 minutes before.
  • Arrange a ride home. You may not drive until the next day.
  • Tell us about any change in your medicines or your health.

This guide is for education and is not medical advice. Your own risks depend on your health and your medicines, and we review them with you at your evaluation.

The takeaway

  • Most side effects happen on treatment day, in the first couple of hours.
  • Dissociation, sleepiness, nausea and a rise in blood pressure are the common ones, and we monitor you for all of them.
  • You may not drive until the next day.

What you can do next

  1. Do not eat for 2 hours or drink for 30 minutes before your dose.
  2. Arrange a ride home.
  3. Tell us right away about chest pain, a severe headache, or pain when you urinate.

Ready to take the next step?

Your first consultation is an evaluation, not a commitment to any treatment. Our patient advocate calls you back within one business day.

Or call us(571) 378-13986849 Old Dominion Drive, Suite 315, McLean

Read our reviews on Google

Call (571) 378-1398Request a consultation